VitaDX develops software solutions for the early diagnosis of cancer based on image processing and artificial intelligence.
Its first solution, VisioCyt®, allows an early detection of bladder cancer, using a simple urine sample.
2.7 million people diagnosed and treated each year.
125,000 new cases/year
4th cause of cancer with 16,282 cases/year4
2nd Urological cancer
Incidence increase of 1%/year
Bladder cancer affects men in over 80% of cases1
Average age of 70 upon diagnosis3
The most common symptoms are hematuria and bladder irritation
People at risk are smokers and professionals exposed to chemicals
Type de tumeur vésicale lors du diagnostic 3
- TVIM 20%
Survie à 5 ans de 50% - TVNIM 80%
Survie à 5 ans de 80%, 50% de récidive dont 15% d’évolution en TVIM
VitaDX was created in April 2015 to enhance a patented technology, combining imagery and artificial intelligence. This technology, based on research carried out by researchers from the Institute of Molecular Sciences in Orsay (ISMO, UMR CNRS and Université Paris-Sud) and practitioners at CHU Bicêtre (AP-HP), aims to diagnose bladder cancer earlier and more reliably.
VitaDX started its first clincal trial in january 2017 and obtained the CE marking for its first solution, VisioCyt®, in February 2020.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Sébastien graduated from ESC Rennes and has over 15 years of experience in the marketing of health products, first in the home care market and then in the medical device market for hospitals and clinics. More recently, he was Marketing Director in the vascular division of the company Terumo. Sébastien is currently in charge of the marketing and clinical departments within VitaDX and he is also involved in the company's development strategy.
Sébastien graduated from ESC Rennes and has over 15 years of experience in the marketing of health products, first in the home care market and then in the medical device market for hospitals and clinics. More recently, he was Marketing Director in the vascular division of the company Terumo. Sébastien is currently in charge of the marketing and clinical departments within VitaDX and he is also involved in the company's development strategy.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Sébastien graduated from ESC Rennes and has over 15 years of experience in the marketing of health products, first in the home care market and then in the medical device market for hospitals and clinics. More recently, he was Marketing Director in the vascular division of the company Terumo. Sébastien is currently in charge of the marketing and clinical departments within VitaDX and he is also involved in the company's development strategy.
Sébastien graduated from ESC Rennes and has over 15 years of experience in the marketing of health products, first in the home care market and then in the medical device market for hospitals and clinics. More recently, he was Marketing Director in the vascular division of the company Terumo. Sébastien is currently in charge of the marketing and clinical departments within VitaDX and he is also involved in the company's development strategy.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
VitaDX is proud to announce its partnership with Medipath, a group of independant pathologists specialized in locally based diagnostics and…
VitaDX is proud to announce its partnership with Medipath, a group of independant pathologists specialized in locally based diagnostics and…
35000 Rennes, France
75015 Paris, France
We are constantly on the lookout for new talent. You can consult our offers or submit a spontaneous application.